Dr Michie is a consultant medical oncologist, honorary clinical senior lecturer and NRS research clinician at the Edinburgh Cancer Centre & University of Edinburgh. She is principal investigator on several clinical trials in breast cancer and UK chief investigator for the DESTINY BREAST-09 study. She is currently the lead clinician for the Edinburgh breast cancer clinical trial team and the Lead Clinician for Systemic Anti Cancer Therapy (SACT) for NHS Fife.
As lead clinician for the trials team, she oversees the trial portfolio and is the first port of call for potential collaboration for clinical trials in breast cancer with industry or investigator-led studies. The portfolio aims to have studies available for all the main breast cancer subtypes in both the curative and metastatic settings, aiming to be able to offer clinical trial access to as many patients with breast cancer as possible. Edinburgh was selected by Astra Zeneca as one of their preferred UK sites for clinical trial collaboration in 2022 and was the lead UK or Europe recruiter for several studies over recent years. The trial team comprises 4-5 dedicated research nurses and 5 data managers, in addition to 7 medical oncology and 5 clinical oncology investigators. There are also regional clinical trial teams in Fife, St Johns, Borders General Hospital and Dumfries and Galloway Royal Infirmary.
